Not Tagged
gilead sciences
['gilead']
chairman and ceo daniel o'day joined today at #asco22 to talk about gilead's progress in advancing new innovations for difficult-to-treat cancers. 
The impossible is not impossible. It’s simply what hasn’t been achieved yet. Twitter guidelines: https://t.co/vWkdtfUf7N